RNAi factors are present and active in human cell nuclei.

Gagnon KT, Li L, Chu Y, Janowski BA, Corey DR. · 2014

Read RNAi factors are present and active in human cell nuclei. by Gagnon KT, Li L, Chu Y, Janowski BA, Corey DR. (2014) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3916906.txt.

Introduction

Keith T. Gagnon, Liande Li, Yongjun Chu, Bethany A. Janowski, and David R. Corey report in Cell Reports in 2014 that the gene-silencing machinery of RNA interference also works inside the human cell nucleus. RNA interference, in which small RNAs guide proteins to cut or block matching RNA, was long treated as a process of the cytoplasm, the cell region outside the nucleus. Its presence in the nucleus had been debated for years.

The team found Argonaute-2 and partner factors Dicer, TRBP, and TNRC6A together in human nuclei, in multi-protein complexes. Small RNAs could silence nuclear RNA and guide cutting at exact sites, and nuclear Dicer was active. One step differed: loading of double-stranded small RNAs onto Argonaute-2 was not seen in the nucleus, suggesting loading is handled differently in the two compartments.

Catalog record

CREATORGagnon KT, Li L, Chu Y, Janowski BA, Corey DR.
YEAR2014
COLLECTIONPAPERS
FORMATTXT
FILE SIZE54 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3916906

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

RNAi Factors are Present and Active in Human Cell Nuclei By Keith T Gagnon, Liande Li, Yongjun Chu, Bethany A Janowski, David R Corey Published in: Cell reports DOI: 10.1016/j.celrep.2013.12.013 ABSTRACT Summary RNAi is widely appreciated as a powerful regulator of mRNA translation in the cytoplasm of mammalian cells. However, the presence and activity of RNAi factors in the mammalian nucleus has been the subject of considerable debate. Here we show that Argonaute-2 (Ago2) and RNAi factors Dicer, TRBP and TRNC6A/GW182 are in the human nucleus and associate together in multi-protein complexes. Small RNAs can silence nuclear RNA and guide site-specific cleavage of the targeted RNA, demonstrating that RNAi can function in the human nucleus. Nuclear Dicer is active and miRNAs are bound to nuclear Ago2, consistent with the existence of nuclear miRNA pathways. Notably, we do not detect loading of duplex small RNAs in nuclear extracts and known loading factors are absent. These results extend RNAi into the mammalian nucleus and suggest that regulation of RNAi via small RNA loading of Ago2 differs between the cytoplasm and the nucleus. INTRODUCTION Since the discovery of mammalian RNA interference (RNAi) (Elbashir et al., 2001), over 50,000 reports have described the use of small interfering RNAs (siRNAs). Almost all of these studies have assumed that the regulation of RNAi and its silencing activity occurs in the cytoplasm (Gurtan and Sharp, 2013). Whether RNAi can function in the mammalian nucleus and regulate processes like transcription or splicing has remained unclear (Castel and Martienssen, 2013; Harel-Bellan et al., 2013). Likewise, what role the nuclear compartment might play in the regulation of RNAi pathways is unknown. These uncertainties have significantly hampered investigation of nuclear RNA biology and the development of nuclear RNAi as a laboratory tool and potential therapeutic. The assumption that mammalian RNAi is confined to the cytoplasm has been supported by reports that siRNAs cannot silence introns (Vickers et al., 2003; Zeng and Cullen, 2002). In addition, microscopy has shown a cytoplasmic distribution of RNAi factors, such as argonaute 2 (Ago2), to p-bodies and the endoplasmic reticulum (ER) (Ikeda et al., 2006; Stalder et al., 2013). Some laboratories, however, have suggested that Ago2 and other RNAi factors can be found in the nucleus (Ando et al., 2011; Chu et al., 2010; Doyle et al., 2013; Ohrt et al., 2012; Rudel et al., 2008; Till et al., 2007; Weinmann et al., 2009). siRNAs have been reported to silence the nuclear enriched RNAs 7SK and U6 (Ohrt et al., 2008; Robb et al., 2005). Although nuclear RNAi activity and localization of RNAi factors to the nucleus have been reported previously, questions about the purity of cell extracts (Holding, 2005), the resolution of localization studies, and nucleocytoplasmic transport of the RNA targets and products of RNAi have kept nuclear RNAi a controversial subject. MicroRNAs (miRNAs) enter the RNAi pathway by binding Ago proteins (Gurtan and Sharp, 2013). In the cytoplasm, miRNAs guide Ago proteins to 3′ untranslated regions and destabilize or inhibit translation of mRNAs (Bartel, 2009; Gurtan and Sharp, 2013; Valencia-Sanchez et al., 2006). miRNAs have also been found in the nucleus (Jeffries et al., 2011; Katahira and Yoneda, 2011; Liao et al., 2010) but their biological roles are unknown. Both synthetic siRNAs and microRNAs have been shown to induce changes in splicing (Allo et al., 2009; Liu et al., 2012) and transcription (Janowski et al., 2007; Li et al., 2006; Matsui et al., 2013; Morris et al., 2004). However, the mechanisms mediating these processes remain controversial, due in part to the debate over the presence and activity of nuclear RNAi factors. During cytoplasmic RNAi, small RNA loads into the RNA induced silencing complex (RISC), the complex recognizes a complementary RNA target, and target cleavage can occur at a specific site (Wilson and Doudna, 2013). Several factors have been implicated in the loading of small RNAs into Ago proteins (programming) and the maturation of RISC in human cells. These include the protein folding chaperones Hsp90 and Hsc70 (Iwasaki et al., 2010) and the component 3 promoter of RNAi (C3PO) complex composed of Translin and TRAX (Ye et al., 2011). Hsp90/Hsc70 are implicated in chaperone-like mechanisms that may open Ago proteins to accommodate the initial binding of a duplex RNA (Iwasaki et al., 2010). In addition, Hsp90 chaperone activity in RNAi programming and RISC maturation has been shown to be dependent on the presence of co-chaperones, including Aha1, FKBP4/5, Cdc37 and p23 (Martinez et al., 2013; Pare et al., 2013). C3PO possesses single-strand nuclease activity and has been shown to accelerate passenger strand RNA removal from Ago to mature the RISC complex (Liu et al., 2009; Ye et al., 2011). Ago2 binds small duplex RNA and forms the core of RISC (Hammond et al., 2000; MacRae et al., 2008; Wilson and Doudna, 2013). Other key players involved in RISC include the pre-miRNA processing enzyme Dicer, the TAR RNA-binding protein (TRBP), and TNRC6A (GW182 homolog) (Daniels and Gatignol, 2012; Lazzaretti et al., 2009; Ma et al., 2012; MacRae et al., 2008). Ago-RISC complexes recognize RNAs complementary to the guide strand (Hammond et al., 2000). When the guide strand is fully complementary to target RNA, Ago2 can catalyze site-specific phosphodiester bond cleavage (“slicer” activity) (Liu et al., 2004; Meister et al., 2004; Wang et al., 2008). To resolve the controversy over mammalian nuclear RNAi, we investigated the localization, interaction, and activity of known RNAi factors in human cell nuclei. Here we show that Ago2 and other RNAi factors are present in the nucleus and can associate in multi-protein complexes. Small RNAs in complex with Ago2 can silence nuclear RNA and induce site-specific cleavage. Nuclear Dicer is catalytically active and miRNAs are bound to nuclear Ago2. In contrast, we did not detect loading of duplex RNA in nuclei and most RISC loading factors are absent. These results place the protein machinery necessary for RNAi recognition inside the mammalian cell nucleus but suggest key differences between nuclear and cytoplasmic RNAi. RESULTS RNAi Factors are Present in Human Cell Nuclei We began our study by using HeLa cells to examine the localization of Ago2, the catalytic core of RNAi (Liu et al., 2004). We used wide-field immuno-epifluorescence microscopy with blind deconvolution because the technique is ideal for rapid and high sensitivity 3-D imaging for thin specimens such as cells in monolayer culture (Shaw, 2006). In some cases, we also used confocal immunofluorescence microscopy for comparison. The success of immuno-fluorescence often depends on conditions like fixation and permeabilization, antibody binding, and cell type (Katikireddy and O'Sullivan, 2011). To improve detection of nuclear proteins, we used protocols designed to facilitate entry of antibody into the nucleus (Spector, 2011). Our microscopy revealed a substantial amount of Ago2 in the nucleus in addition to the expected distribution within the cytoplasm. Images of slices through several micrometer thick sections along the z-axis, combined with 3-D rendering of composite focal sections, revealed Ago2 within the nuclear compartment (Figure 1; Movie S1). The application of two additional antibodies against human Ago2 produced similar results (Figure S1A-C), confirming that nuclear visualization was not due to off-target immunoreactivity. We also observed Ago2 in the nuclei of T47D breast cancer cells and fibroblast cells (Figure S1D-F), indicating that nuclear Ago2 is

Read the complete text